Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes
Konstantinos Theofilatos,Stefan Stojkovic,Maria Hasman,Sander W van der Laan,Ferheen Baig,Javier Barallobre-Barreiro,Lukas Schmidt,Siqi Yin,Xiaoke Yin,Sean Burnap,Bhawana Singh,Jude Popham,Olesya Harkot,Stephanie Kampf,Maja Carina Nackenhorst,Andreas Strassl,Christian Loewe,Svitlana Demyanets,Christoph Neumayer,Martin Bilban,Christian Hengstenberg,Kurt Huber,Gerard Pasterkamp,Johann Wojta,Manuel Mayr,Sander W. van der Laan
DOI: https://doi.org/10.1161/circresaha.123.322590
IF: 23.213
2023-08-31
Circulation Research
Abstract:Circulation Research, Ahead of Print. Background:Using proteomics, we aimed to reveal molecular types of human atherosclerotic lesions and study their associations with histology, imaging, and cardiovascular outcomes.Methods:Two hundred nineteen carotid endarterectomy samples were procured from 120 patients. A sequential protein extraction protocol was employed in conjunction with multiplexed, discovery proteomics. To focus on extracellular proteins, parallel reaction monitoring was employed for targeted proteomics. Proteomic signatures were integrated with bulk, single-cell, and spatial RNA-sequencing data, and validated in 200 patients from the Athero-Express Biobank study.Results:This extensive proteomics analysis identified plaque inflammation and calcification signatures, which were inversely correlated and validated using targeted proteomics. The inflammation signature was characterized by the presence of neutrophil-derived proteins, such as S100A8/9 and myeloperoxidase, whereas the calcification signature included fetuin-A, osteopontin, and gamma-carboxylated proteins. The proteomics data also revealed sex differences in atherosclerosis, with large-aggregating proteoglycans versican and aggrecan being more abundant in females and exhibiting an inverse correlation with estradiol levels. The integration of RNA-sequencing data attributed the inflammation signature predominantly to neutrophils and macrophages, and the calcification and sex signatures to smooth muscle cells, except for certain plasma proteins that were not expressed but retained in plaques, such as fetuin-A. Dimensionality reduction and machine learning techniques were applied to identify 4 distinct plaque phenotypes based on proteomics data. A protein signature of 4 key proteins (calponin, protein C, serpin H1, and versican) predicted future cardiovascular mortality with an area under the curve of 75% and 67.5% in the discovery and validation cohort, respectively, surpassing the prognostic performance of imaging and histology.Conclusions:Plaque proteomics redefined clinically relevant patient groups with distinct outcomes, identifying subgroups of male and female patients with elevated risk of future cardiovascular events.
cardiac & cardiovascular systems,peripheral vascular disease,hematology